SHS Gesellschaft für Beteiligungsmanagement mbH

DE | ∗ EN | 中文

Main menu

Skip to primary content

Skip to secondary content

Home
About us
Venture Capital
- Investment process
- Contact for entrepreneurs
Private Equity
- Reason for an Investment
- Contact for entrepreneus
Investors
Portfolio
- Active Investments
- Selected exits
News
Career
- Career at SHS and Portfolio
- Internship
Contact
- Impressum
- Privacy Policy

Contact for investors

Hubertus Leonhardt, CFA
Managing Partner

T: +49 (0)7071 – 9169-0
EMail: investorinfo@shs-capital.eu

News

Are you interested in receiving regular updates about SHS?
Subscribe to our newsletter

SHS invests in Swiss life science company evitria AG

The life science company supplies large pharmaceutical and biotech companies with customized antibodies for research purposes. For SHS, it is the first investment from its SHS V fund, which had its first closing in July 2018.

SHS sells shareholding in Emerging Implant Technologies GmbH to Johnson & Johnson Medical GmbH

We have sold our shareholding in Tuttlingen-based Emerging Implant Technologies GmbH (EIT) to Johnson & Johnson Medical GmbH. In 2016 we have invested in the medtech company as lead investor.

First closing at SHS: Medical technology investor raises over €90 million for its fifth fund

The fifth generation of SHS funds is also focused on the life sciences and medical technology sector, and thus on the growing global healthcare market with innovative and strong Players.

SHS portfolio company Novo acquires respiratory products supplier Innocath

With the acquisition of Innocath, Novo Klinik-Service is complementing its product portfolio in the field of airway management. The partnership will open up further growth opportunities and sales activities.

Frankfurter Allgemeine Zeitung: New fund for medical technology - SHS Beteiligungsgesellschaft raises 150 million euros

SHS partner Dr. André Zimmermann talks to the FAZ about SHS’ new medical technology fund

Miracor Medical raises € 25m

Miracor Medical Systems has raised the capital as part of a Series D financing round. Next to other existing investors SHS also participated in the financing round.

Investment Plan for Europe: EIB grants financing to pharmaceutical company AMW

The European Investment Bank (EIB) will provide financing of EUR 25m to AMW GmbH in Warngau, Germany. The financing will enable AMW to increase R&D activities, conduct clinical trials and expand production capacity.

SHS invests in innovative heart valve-repair start-up CoreMedic

CoreMedic is a start-up developing innovative, transfemoral repair systems to treat heart valve malfunctions. SHS is investing from its fourth fund generation to finance CoreMedic’s further growth and the clinical application of its innovative products.

Direct access

You are Entrepreneur
You are Investor

Career at SHS
Internship at SHS

Contact

Mail us
Contact details

Impressum | Privacy Policy | Newsletter | Admin
Copyright © 2016 SHS Gesellschaft für Beteiligungsmanagement mbH

This website uses cookies. If you continue your visit you agree to the use of cookies. You can find more information here: Privacy Policy Accept